STOCK TITAN

Dassault Systemes Stock Price, News & Analysis

DASTY OTC

Welcome to our dedicated page for Dassault Systemes news (Ticker: DASTY), a resource for investors and traders seeking the latest updates and insights on Dassault Systemes stock.

DASSAULT SYSTEMES SA ADR (DASTY) news on Stock Titan reflects the official communications of Dassault Systèmes, a software publisher in the information sector whose underlying shares trade on Euronext Paris as DSY.PA. The company’s releases provide insight into its 3DEXPERIENCE platform, virtual worlds strategy and AI-embedded software offerings, as well as its capital markets activity.

Investors following DASTY can use this page to review earnings and financial updates, where Dassault Systèmes reports quarterly and year-to-date revenue, software revenue, recurring revenue, operating margin and diluted earnings per share under IFRS and non-IFRS measures. These announcements also break down software revenue by geography, product line and industry, and highlight the contribution of areas such as Industrial Innovation, Life Sciences and Mainstream Innovation.

The news feed also includes corporate and strategic announcements, such as information about Medidata, a Dassault Systèmes brand that provides clinical trial solutions. Releases describe Medidata Patient, Data and Study Experiences and collaborations with life sciences companies like Sanofi, emphasizing goals such as streamlining clinical workflows, enhancing data quality and accelerating the development of new therapies.

In addition, Dassault Systèmes publishes regulatory and capital markets disclosures, including declarations of the number of outstanding shares and voting rights, reports on trading in its own shares under repurchase programs, and half-year statements on its liquidity contract. Bookmark this page to access a consolidated view of these official updates related to DASTY and the underlying Dassault Systèmes shares.

Rhea-AI Summary

Dassault Systèmes disclosed its trading activities in its own shares on February 25 and 26, 2021, based on a buyback program approved at the General Meeting of Shareholders on May 26, 2020. The report details transactions by market and day, indicating that a total of 16,289 shares were purchased at an average price of €171.9886 on February 25, while 51,778 shares were acquired at €171.7171 on February 26. For more comprehensive transaction details, investors can visit the company's dedicated investor relations page.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.56%
Tags
none
-
Rhea-AI Summary

Dassault Systèmes has announced its total number of outstanding shares and voting rights as of January 31, 2021. The company reports a total of 265,165,590 outstanding shares and 397,116,008 voting rights. This calculation includes shares with suspended voting rights, in compliance with the General Regulation of Autorité des marchés financiers. Shareholders are reminded to declare any crossing of threshold notifications to the company's Investor Relations Service.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.1%
Tags
none
-
Rhea-AI Summary

Dassault Systèmes reported its fourth-quarter and full-year financial results for 2020, showcasing resilience despite the pandemic. Q4 total revenue increased 7% to €1.22 billion (IFRS), with non-IFRS total revenue of €1.22 billion up 5%. FY recurring revenue grew 27% to €3.2 billion, accounting for 80% of total software revenue. The company projects 2021 total revenue growth of 9% to 10%. EPS for the year was €1.86 (IFRS) and €3.77 (non-IFRS), with cash flow from operations rising 5% to €1.24 billion. Strong performance from MEDIDATA and ongoing R&D investments were highlighted.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.82%
Tags
Rhea-AI Summary

Medidata, a Dassault Systèmes company, has expanded its partnership with Horizon Therapeutics to enhance clinical trial efficiencies across various therapeutic areas such as ophthalmology, rheumatology, and nephrology. The collaboration builds on a successful relationship that began in 2017. Medidata will provide Horizon with an extensive suite of clinical trial solutions, including the Medidata Rave Clinical Cloud and Intelligent Trials, which utilizes AI for data analytics and performance metrics. This partnership is expected to facilitate faster completion of clinical studies and improve overall trial management.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.82%
Tags
partnership clinical trial
-
Rhea-AI Summary

Dassault Systèmes will announce its third-quarter 2020 results on October 22, 2020. The results will cover the period ending September 30, 2020. A webcast is scheduled for 10:00 AM Paris time and a conference call at 9:00 AM New York time. Both events will be available live and as replays on their investor website. Investors are advised to connect at least fifteen minutes early to ensure they can access the required software. Dassault Systèmes supports over 270,000 customers globally across various industries.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.09%
Tags
conferences earnings
-
Rhea-AI Summary

Dassault Systèmes announced the number of outstanding shares and voting rights as of September 30, 2020. The total number of outstanding shares is 264,919,418, while the total voting rights amount to 396,990,201. This information complies with the regulations set by the Autorité des marchés financiers. Shareholders are reminded to refer to Article 223-11 for details regarding the calculation of voting rights, particularly in instances of threshold crossings. Declarations related to threshold crossings should be directed to the Investor Relations Service.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.22%
Tags
none

FAQ

What is the current stock price of Dassault Systemes (DASTY)?

The current stock price of Dassault Systemes (DASTY) is $22.52 as of May 1, 2026.

What is the market cap of Dassault Systemes (DASTY)?

The market cap of Dassault Systemes (DASTY) is approximately 29.5B.